Evidence-based recommendations on biomarker tests to help diagnose preterm labour in women with intact membranes. The tests are Actim Partus, PartoSure and the Rapid fetal fibronectin (fFN) 10Q Cassette Kit (at thresholds other than 50 nanograms/millilitre).

Is this guidance up to date?

Next review: 2021

Guidance development process

How we develop NICE diagnostics guidance

  • National Institute for Health and Care Excellence (NICE)